Clinical Disintegration Time of Orally Disintegrating Tablets Clinically Available in Japan in Healthy Volunteers
スポンサーリンク
概要
- 論文の詳細を見る
Disintegration time is an important characteristic of orally disintegrating tablets (ODTs), and evaluation of disintegration time is a key step in formulation development, manufacturing, and clinical practice. In this study, we aimed to clarify the clinical disintegration time of ODTs that are currently used clinically, and to evaluate its correlation with the in vitro disintegration time of ODTs which was measured using Tricorptester, a newly developed disintegration testing apparatus. The clinical disintegration time of 17 ODT products was measured in healthy volunteers (n=9–10; age range, 21–28 years). A randomized single-blind trial was performed; each tablet was placed on the tongues of the participants, and it disintegrated in their oral cavities. No significant difference was observed in the clinical disintegration time of each ODT among the 3 groups to which the subjects were randomly assigned. The clinical disintegration time of the 17 ODT products was between 17.6 s and 33.8 s. The in vitro disintegration time of 26 clinically used ODT products measured using Tricorptester ranged between 4.40 s and 30.4 s. A significant positive correlation was observed between in vitro and clinical disintegration times (r=0.79; p<0.001). This study shows that all the tested products, which are clinically available in Japan, showed good disintegration and that the disintegration time varied according to the product. In addition, the in vitro disintegration time of ODTs measured using Tricorptester is a good reflection of the disintegration time in the oral cavity.
著者
-
Namiki Noriyuki
Department Of Earth And Planetary Sciences Kyushu University
-
Uchida Shinya
Department Of Anesthesiology Gunma University Hospital
-
Uchida Shinya
Department of Pharmacy Practice and Science, School of Pharmaceutical Sciences University of Shizuoka
-
Yoshita Tomohiro
Department of Pharmacy Practice and Science, School of Pharmaceutical Sciences University of Shizuoka
-
Namiki Noriyuki
Department of Clinical Pharmacology & Therapeutics, Hamamatsu University School of Medicine
-
Namiki Noriyuki
Department of Pharmacy Practice and Science, School of Pharmaceutical Sciences University of Shizuoka
関連論文
- Structure-Activity Relationships of Receptor Binding of 1,4-Dihydropyridine Derivatives(Pharmacology)
- PJ-566 Influence of CYP2C9 Genotype on Pharmacokinetics and Pharmacodynamics of Benzbromarone(Cardiovascular pharmacology, basic/clinical-6, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-002 Influence of Genetic Polymorphisms of OATP-C on Cholesterol Lowering Effect of Pravastatin(Cardiovascular pharmacology, basic/clinical-2 (H) OJ1,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation
- OE-271 Pharmacokinetic and pharmacodynamic interactions between simvastatin and diltiazem in patients with hypercholesterolaemia and hypertension(Cardiovascular Pharmacology, Basic/Clinical 1 (H) : OE34)(Oral Presentation (English))
- Interaction between Amlodipine and Simvastatin in Patients with Hypercholesterolemia and Hypertension
- Antinociceptive Effects of St. John's Wort, Harpagophytum Procumbens Extract and Grape Seed Proanthocyanidins Extract in Mice(Pharmacology)
- Low Dosage of Streptozotocin and Fat-diet Reduced Rat Liver Insulin Receptor Activities
- Evaluation on Rat Model of Metabolic Syndrome Induced by Fat-diet and Streptozotocin
- Studies on Development of Dosage Forms for Pediatric Use (V) Oral Mucosal Irritation Study of Gummi Drugs in Hamster Cheek Pouch
- Studies on Development of Dosage Form for Pediatric Use (No.4) Time Courses of Plasma Concentration of Acetaminophen after Oral Administration of Gummi Drug and Powder Preparation in Dogs
- Blood-Brain Permeability of [^3H]-(3-methyl-His^2) Thyrotropin-releasing Hormone (MeTRH) in Mice : Effects of TRH and its Analogues
- In Vivo Measurement of 1, 4-Dihydropyridine Receptors in Mesenteric Arteries of Spontaneously Hypertensive Rats and Effect of Nifedipine and Cilnidipine
- Onset of Clinical Effects and Plasma Concentration of Fluvoxamine in Japanese Patients
- Effects of Cigarette Smoking and Cytochrome P450 2D6 Genotype on Fluvoxamine Concentration in Plasma of Japanese Patients
- Benzbromarone Pharmacokinetics and Pharmacodynamics in Different Cytochrome P450 2C9 Genotypes
- Formulation Study for Orally Disintegrating Tablet Using Partly Pregelatinized Starch Binder
- Testing hypotheses for the origin of steep slope of lunar size-frequency distribution for small craters
- Adequacy of control of preoperative hypertension can affect landiolol-induced hemodynamic changes in elderly patients during emergence from anesthesia
- Taste-Masking Effect of Physical and Organoleptic Methods on Peppermint-Scented Orally Disintegrating Tablet of Famotidine Based on Suspension Spray-Coating Method
- Clinical Disintegration Time of Orally Disintegrating Tablets Clinically Available in Japan in Healthy Volunteers
- Nondestructive Evaluation of Setting and Hardening of Cement Paste Based on Ultrasonic Propagation Characteristics
- Plasma Concentration and Occupation of Calcium (Ca2+) Antagonist Receptors of Amlodipine, a Long-acting Ca2+ Antagonist in SHR
- Simultaneous LC-MS/MS Analysis of the Plasma Concentrations of a Cocktail of 5 Cytochrome P450 Substrate Drugs and Their Metabolites
- Comparison of Inhibitory Duration of Grapefruit Juice on Organic Anion-Transporting Polypeptide and Cytochrome P450 3A4